Paxlovid Remains Potent Against Omicron COVID Cases
MONDAY, Feb. 13, 2023 (HealthDay News) — The COVID-19 antiviral treatment Paxlovid continues to work against Omicron subvariants BA.4 and BA.5, new research shows. Researchers decided to study Paxlovid’s impact against severe illness and death because doctors have fewer treatment options for high-risk patients as the virus evolves. “We areContinue Reading